u/paul-steven-m — thesis ledger

Window	Theses	Resolved	Win rate	Avg return	Median return
1d	1	1	0%	-2.3%	-2.3%
3d	1	1	0%	-2.3%	-2.3%
1w	1	1	0%	-8.7%	-8.7%
1m	0	0	—	—	—
3m	0	0	—	—	—
6m	0	0	—	—	—
1y	0	0	—	—	—

Window

Theses

Resolved

Wins

Win rate

Avg return

Median return

-2.3%

-8.7%

—

Thesis history

$RAPPSEC Form 4bullish

PAUL STEVEN M · Rapport Therapeutics, Inc. · 8d agono track record yet

Long 35,714 shares of RAPP

Bought 35,714 @ $27.28 avg · $974,278 · 2026-10-22

Form 4: PAUL STEVEN M bought RAPP

PAUL STEVEN M (Director at Rapport Therapeutics, Inc.) reported an open-market purchase of 35,714 shares of RAPP at an average $27.28, roughly $974,278, in a Form 4 filed 2026-10-22.

At post $26.53Now $24.21-8.7% since postedas of Oct 29, 4:01 PM ET

1d-2.3%

3d-2.3%

1w-8.7%

1m—

3m—

6m—

1y—

View filing on SEC.gov →

End of results.